Clinical Trial Update: A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the combination of tocilizumab (RoActemra/Actemra) with methotrexate for articular damage in the hand in rheumatoid arthritis has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• RoActemra/Actemra (tocilizumab) (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 4 | Status: WITHDRAWN